Erlosiban, also known as OBE001, is a novel, orally active nonpeptide oxytocin receptor antagonist under development for the treatment of preterm labor and improvement in embryo implantation and pregnancy rate in assisted reproductive technology (ART).
Molekulargewicht:
338.4
CAS Nummer:
[1477482-19-1]
Formel:
C20H22N2O3
Target-Kategorie:
Others
T70570
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten